Literature DB >> 14517702

P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.

Bartosz Dybowski1, Jolanta Kupryjańczyk, Alina Rembiszewska, Roman Pykało, Andrzej Borkowski.   

Abstract

P27(Kip1) protein is a cell cycle inhibitor which blocks the transition of cells from G1 to S phase, while Ki-67 is the most specific marker of proliferative activity. Both proteins are independent predictors of clinical outcome in various neoplasms. The aim of the study was to assess the prognostic value of p27(Kip1) and Ki-67 expression in urothelial bladder tumours. P27(Kip1) and Ki-67 expressions were evaluated immunohistochemically in archival samples of 45 superficial and 26 invasive transitional cell carcinomas obtained by a transurethral resection. In the patients with superficial tumours, disease-free survival (DFS) was positively influenced by good histological differentiation as well as by concurrent high p27(Kip1) and low Ki-67 expression. Multivariate analysis has confirmed that tumour grade and p27(Kip1)/Ki-67 status were independent predictors of DFS ( p=0.028 and p=0.029, respectively). P27(Kip1) or Ki-67 expressions did not influence overall survival. We conclude that a variable combined of p27(Kip1) and Ki-67 expressions is a better predictor of DFS in superficial bladder tumours than either protein alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517702     DOI: 10.1007/s00240-003-0356-8

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  36 in total

1.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

2.  Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification.

Authors:  Lúcio Santos; Teresina Amaro; Céu Costa; Sofia Pereira; Maria José Bento; Paula Lopes; Jorge Oliveira; Begoña Criado; Carlos Lopes
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

3.  Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.

Authors:  P Gontero; G Casetta; A Zitella; R Ballario; D Pacchioni; C Magnani; G H Muir; A Tizzani
Journal:  Eur Urol       Date:  2000-09       Impact factor: 20.096

4.  MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors.

Authors:  J W Oosterhuis; R F Schapers; M L Janssen-Heijnen; A W Smeets; R P Pauwels
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

5.  Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

Authors:  V Esposito; A Baldi; A De Luca; A M Groger; M Loda; G G Giordano; M Caputi; F Baldi; M Pagano; A Giordano
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

6.  Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.

Authors:  J J Del Pizzo; A Borkowski; S C Jacobs; N Kyprianou
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

7.  Superficial bladder cancer: progression and recurrence.

Authors:  N M Heney; S Ahmed; M J Flanagan; W Frable; M P Corder; M D Hafermann; I R Hawkins
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

8.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

Authors:  M V Ponce-Castañeda; M H Lee; E Latres; K Polyak; L Lacombe; K Montgomery; S Mathew; K Krauter; J Sheinfeld; J Massague
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

9.  Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

Authors:  L A Kiemeney; J A Witjes; R P Heijbroek; A L Verbeek; F M Debruyne
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

10.  Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.

Authors:  T Kamai; K Takagi; H Asami; Y Ito; H Oshima; K I Yoshida
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

View more
  4 in total

1.  Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.

Authors:  A Quintero; J Alvarez-Kindelan; R J Luque; R Gonzalez-Campora; M J Requena; R Montironi; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms.

Authors:  E Compérat; P Camparo; R Haus; E Chartier-Kastler; B Radenen; F Richard; F Capron; V Paradis
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

3.  Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.

Authors:  Taghreed A Abd Elazeez; Abd El-Latef M El-Balshy; Mostafa M Khalil; Magdy M El-Tabye; Hamdy Abdul-Halim
Journal:  Urol Ann       Date:  2011-01

4.  Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.

Authors:  Kyungtae Ko; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.